113 related articles for article (PubMed ID: 12149925)
1. [Neoplastic chondroneogenesis as a characteristic of mesenchymal chondrosarcomas].
Schörle CM; Unni KK; Aigner T
Orthopade; 2002 Jun; 31(6):544-50. PubMed ID: 12149925
[TBL] [Abstract][Full Text] [Related]
2. Cell differentiation and matrix gene expression in mesenchymal chondrosarcomas.
Aigner T; Loos S; Müller S; Sandell LJ; Unni KK; Kirchner T
Am J Pathol; 2000 Apr; 156(4):1327-35. PubMed ID: 10751358
[TBL] [Abstract][Full Text] [Related]
3. Type II collagen as specific marker for mesenchymal chondrosarcomas compared to other small cell sarcomas of the skeleton.
Müller S; Söder S; Oliveira AM; Inwards CY; Aigner T
Mod Pathol; 2005 Aug; 18(8):1088-94. PubMed ID: 15731776
[TBL] [Abstract][Full Text] [Related]
4. Towards a new understanding and classification of chondrogenic neoplasias of the skeleton--biochemistry and cell biology of chondrosarcoma and its variants.
Aigner T
Virchows Arch; 2002 Sep; 441(3):219-30. PubMed ID: 12242518
[TBL] [Abstract][Full Text] [Related]
5. Reappraisal of mesenchymal chondrosarcoma: novel morphologic observations of the hyaline cartilage and endochondral ossification and beta-catenin, Sox9, and osteocalcin immunostaining of 22 cases.
Fanburg-Smith JC; Auerbach A; Marwaha JS; Wang Z; Rushing EJ
Hum Pathol; 2010 May; 41(5):653-62. PubMed ID: 20138330
[TBL] [Abstract][Full Text] [Related]
6. Matrix gene expression analysis and cellular phenotyping in chordoma reveals focal differentiation pattern of neoplastic cells mimicking nucleus pulposus development.
Gottschalk D; Fehn M; Patt S; Saeger W; Kirchner T; Aigner T
Am J Pathol; 2001 May; 158(5):1571-8. PubMed ID: 11337353
[TBL] [Abstract][Full Text] [Related]
7. Type II collagen, but not aggrecan expression, distinguishes clear cell chondrosarcoma and chondroblastoma.
Söder S; Oliveira AM; Inwards CY; Müller S; Aigner T
Pathology; 2006 Feb; 38(1):35-8. PubMed ID: 16484006
[TBL] [Abstract][Full Text] [Related]
8. Cell biology and matrix biochemistry of chondromyxoid fibroma.
Söder S; Inwards C; Müller S; Kirchner T; Aigner T
Am J Clin Pathol; 2001 Aug; 116(2):271-7. PubMed ID: 11488075
[TBL] [Abstract][Full Text] [Related]
9. Type X collagen expression and hypertrophic differentiation in chondrogenic neoplasias.
Aigner T; Frischholz S; Dertinger S; Beier F; Girkontaité I; von der Mark K
Histochem Cell Biol; 1997 Jun; 107(6):435-40. PubMed ID: 9243276
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic diversity of neoplastic chondrocytes and extracellular matrix gene expression in cartilaginous neoplasms.
Aigner T; Dertinger S; Vornehm SI; Dudhia J; von der Mark K; Kirchner T
Am J Pathol; 1997 Jun; 150(6):2133-41. PubMed ID: 9176404
[TBL] [Abstract][Full Text] [Related]
11. [Matrix gene expression pattern as indicators of the biology of cartilage-forming tumors].
Aigner T; Unni CC; Bjornsson J; Kirchner T
Verh Dtsch Ges Pathol; 1998; 82():178-83. PubMed ID: 10095430
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal chondrosarcoma: an immunohistochemical study of 10 cases examining prognostic significance of proliferative activity and cellular differentiation.
Nussbeck W; Neureiter D; Söder S; Inwards C; Aigner T
Pathology; 2004 Jun; 36(3):230-3. PubMed ID: 15203726
[TBL] [Abstract][Full Text] [Related]
13. Prognostic relevance of cell biologic and biochemical features in conventional chondrosarcomas.
Aigner T; Müller S; Neureiter D; Illstrup DM; Kirchner T; Björnsson J
Cancer; 2002 Apr; 94(8):2273-81. PubMed ID: 12001127
[TBL] [Abstract][Full Text] [Related]
14. Congenital intracranial mesenchymal chondrosarcoma: case report and review of the literature in pediatric patients.
De Cecio R; Migliaccio I; Falleti J; Del Basso De Caro M; Pettinato G
Pediatr Dev Pathol; 2008; 11(4):309-13. PubMed ID: 17990930
[TBL] [Abstract][Full Text] [Related]
15. Runx1/AML1/Cbfa2 mediates onset of mesenchymal cell differentiation toward chondrogenesis.
Wang Y; Belflower RM; Dong YF; Schwarz EM; O'Keefe RJ; Drissi H
J Bone Miner Res; 2005 Sep; 20(9):1624-36. PubMed ID: 16059634
[TBL] [Abstract][Full Text] [Related]
16. Quantification of expression levels of cellular differentiation markers does not support a general shift in the cellular phenotype of osteoarthritic chondrocytes.
Gebhard PM; Gehrsitz A; Bau B; Söder S; Eger W; Aigner T
J Orthop Res; 2003 Jan; 21(1):96-101. PubMed ID: 12507585
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical distribution of S-100 protein in tumors and tumor-like lesions of bone and cartilage.
Okajima K; Honda I; Kitagawa T
Cancer; 1988 Feb; 61(4):792-9. PubMed ID: 3276387
[TBL] [Abstract][Full Text] [Related]
18. Giant primary mesenchymal chondrosarcoma of the lung: case report and review of literature.
Mei B; Lai YL; He GJ; Shou YN; Liu J
Ann Thorac Cardiovasc Surg; 2013; 19(6):481-4. PubMed ID: 23196662
[TBL] [Abstract][Full Text] [Related]
19. De-differentiated chondrosarcoma is not a 'de-differentiated' chondrosarcoma.
Aigner T; Dertinger S; Neureiter D; Kirchner T
Histopathology; 1998 Jul; 33(1):11-9. PubMed ID: 9726043
[TBL] [Abstract][Full Text] [Related]
20. Differentiation and proliferative activity in benign and malignant cartilage tumors of bone.
Hasegawa T; Seki K; Yang P; Hirose T; Hizawa K; Wada T; Wakabayashi J
Hum Pathol; 1995 Aug; 26(8):838-45. PubMed ID: 7543439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
